Literature DB >> 12243805

Dose-volume factors contributing to the incidence of radiation pneumonitis in non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy.

Ellen D Yorke1, Andrew Jackson, Kenneth E Rosenzweig, Scott A Merrick, Dorota Gabrys, Ennapadam S Venkatraman, Chandra M Burman, Steven A Leibel, C Clifton Ling.   

Abstract

PURPOSE: To analyze acute lung toxicity data of non-small-cell lung cancer patients treated with three-dimensional conformal radiation therapy in terms of dosimetric variables, location of dose within subvolumes of the lungs, and models of normal-tissue complication probability (NTCP). METHODS AND MATERIALS: Dose distributions of 49 non-small-cell lung cancer patients treated in a dose escalation protocol between 1992 and 1999 were analyzed (dose range: 57.6-81 Gy). Nine patients had RTOG Grade 3 or higher acute lung toxicity. Correlation with dosimetric and physical variables, as well as Lyman and parallel NTCP models, was assessed. Lungs were evaluated as a single structure, as superior and inferior halves (to assess significance of dose to upper and lower lungs), and as ipsilateral and contralateral lungs.
RESULTS: For the whole lung, Grade 3 or higher pneumonitis was significantly correlated (p <or= 0.05) with mean dose and Lyman and parallel model indices (d(eff) and f(dam)). It was significantly correlated with these indices and with V20 for the ipsilateral lung and with mean dose and d(eff) for the inferior half of the lungs. Dosimetric and NTCP model quantities for the superior half of the lungs and contralateral lung were not significantly correlated (p > 0.5 for superior lung indices, and >0.1 for contralateral lung indices studied).
CONCLUSIONS: For these patients, commonly used dosimetric and NTCP models are significantly correlated with >or= Grade 3 pneumonitis. Equivalently strong correlations are found in the lower portion of the lungs and the ipsilateral lung, but not in the upper portion or contralateral lung.

Entities:  

Mesh:

Year:  2002        PMID: 12243805     DOI: 10.1016/s0360-3016(02)02929-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  72 in total

1.  4DCT-based measurement of changes in pulmonary function following a course of radiation therapy.

Authors:  Kai Ding; John E Bayouth; John M Buatti; Gary E Christensen; Joseph M Reinhardt
Journal:  Med Phys       Date:  2010-03       Impact factor: 4.071

Review 2.  Radiation dose-volume effects in the lung.

Authors:  Lawrence B Marks; Soren M Bentzen; Joseph O Deasy; Feng-Ming Spring Kong; Jeffrey D Bradley; Ivan S Vogelius; Issam El Naqa; Jessica L Hubbs; Joos V Lebesque; Robert D Timmerman; Mary K Martel; Andrew Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  Does transforming growth factor-beta1 predict for radiation-induced pneumonitis in patients treated for lung cancer?

Authors:  Elizabeth S Evans; Zafer Kocak; Su-Min Zhou; Daniel A Kahn; Hong Huang; Donna R Hollis; Kim L Light; Mitchell S Anscher; Lawrence B Marks
Journal:  Cytokine       Date:  2006-09-18       Impact factor: 3.861

4.  Heart irradiation as a risk factor for radiation pneumonitis.

Authors:  Ellen X Huang; Andrew J Hope; Patricia E Lindsay; Marco Trovo; Issam El Naqa; Joseph O Deasy; Jeffrey D Bradley
Journal:  Acta Oncol       Date:  2010-09-28       Impact factor: 4.089

5.  Effect of deformable registration on the dose calculated in radiation therapy planning CT scans of lung cancer patients.

Authors:  Alexandra R Cunliffe; Clay Contee; Samuel G Armato; Bradley White; Julia Justusson; Renuka Malik; Hania A Al-Hallaq
Journal:  Med Phys       Date:  2015-01       Impact factor: 4.071

Review 6.  Radiation-related treatment effects across the age spectrum: differences and similarities or what the old and young can learn from each other.

Authors:  Matthew J Krasin; Louis S Constine; Debra L Friedman; Lawrence B Marks
Journal:  Semin Radiat Oncol       Date:  2010-01       Impact factor: 5.934

7.  Incidence and correlates of radiation pneumonitis in pediatric patients with partial lung irradiation.

Authors:  Chiaho Hua; Kelly A Hoth; Shengjie Wu; Larry E Kun; Monika L Metzger; Sheri L Spunt; Xiaoping Xiong; Mathew J Krasin
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-07       Impact factor: 7.038

8.  Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Authors:  Sonal Sura; Vishal Gupta; Ellen Yorke; Andrew Jackson; Howard Amols; Kenneth E Rosenzweig
Journal:  Radiother Oncol       Date:  2008-03-17       Impact factor: 6.280

9.  Analysis of clinical and dosimetric factors associated with severe acute radiation pneumonitis in patients with locally advanced non-small cell lung cancer treated with concurrent chemotherapy and intensity-modulated radiotherapy.

Authors:  Anhui Shi; Guangying Zhu; Hao Wu; Rong Yu; Fuhai Li; Bo Xu
Journal:  Radiat Oncol       Date:  2010-05-12       Impact factor: 3.481

10.  Radiotherapy of large target volumes in Hodgkin's lymphoma: normal tissue sparing capability of forward IMRT versus conventional techniques.

Authors:  Laura Cella; Raffaele Liuzzi; Mario Magliulo; Manuel Conson; Luigi Camera; Marco Salvatore; Roberto Pacelli
Journal:  Radiat Oncol       Date:  2010-05-11       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.